Cargando…

Cutaneous polyarteriitis nodosa with Grave’s disease and cholestatic liver disease

Detalles Bibliográficos
Autores principales:	Vassileva, V, Varbanova, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194753/ http://dx.doi.org/10.1186/1546-0096-9-S1-P90

Ejemplares similares

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Severe cholestatic jaundice associated with Graves’ disease
por: Abebe, Abebe, et al.
Publicado: (2018)

Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge
por: Haddaden, Metri, et al.
Publicado: (2021)

Study of antimicrobial potential and cytotoxic of Cordia nodosa species
por: dos Santos, Raíssa Fernanda Evangelista Pires, et al.
Publicado: (2014)

Cutaneous polyarteritis nodosa
por: Matteoda, María Alejandra, et al.
Publicado: (2015)

Outcome of children with panarteritis nodosa: a series of 30 cases
por: Merlin, E, et al.
Publicado: (2011)

Polyarteritis nodosa in childhood - expertise of a rheumatology pediatric unit
por: Abelha-Aleixo, Joana, et al.
Publicado: (2014)

Severe Pulmonary Hypertension and Cholestatic Liver Injury: Two Rare Manifestations of Graves’ Disease
por: Nigussie, Bisrat, et al.
Publicado: (2020)

A case with SLE and Pseudohypoparathyreoidism
por: Varbanova, B, et al.
Publicado: (2008)

Polyarteritis Nodosa (PAN) in childhood: a report of two siblings with intractable disease controlled by mycophenolate mofetil (MMF)
por: Falcini, FF, et al.
Publicado: (2008)

Efficacy and safety of thalidomide in two sisters with severe refractory polyarteritis nodosa (PAN)
por: Vitale, A, et al.
Publicado: (2008)

Monogenic polyarteritis nodosa caused by ADA2 Deficiency: the GOSH experience
por: Nanthapisal, S, et al.
Publicado: (2015)

Elicitation of expert prior opinion: application to the mypan trial in childhood polyarteritis nodosa
por: Hampson, Lisa, et al.
Publicado: (2014)

Single-dose pharmacokinetics of the cholesteryl sulfate complex of amphotericin B in critically ill patients with cholestatic liver failure
por: Weiler, S, et al.
Publicado: (2008)

Congenital adrenal hyperplasia with cholestatic jaundice: a case report
por: Mai, DoThi Thanh, et al.
Publicado: (2015)

Rescue of Graves Thyrotoxicosis-Induced Cholestatic Liver Disease Without Antithyroid Drugs: A Case Report
por: Yan, Lily D., et al.
Publicado: (2017)

Effect of the pregnant mice with Graves’ disease on thyroid function in the offspring
por: Liu, Qianqi, et al.
Publicado: (2013)

Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years
por: Topic, Masa Vikic, et al.
Publicado: (2011)

PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
por: Mihailova, D, et al.
Publicado: (2013)

Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital Jakarta
por: Andriana, Novina, et al.
Publicado: (2013)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

Cutaneous polyarteritis nodosa: A rare isolated cutaneous vasculitis
por: Subbanna, Praveen Kumar A., et al.
Publicado: (2012)

Fulminant skin necrosis and massive deep venous thrombosis as a part of a clinical presentation of polyarteritis nodosa -case report
por: Čengić, Adisa, et al.
Publicado: (2014)

Crohn's Disease with Cutaneous Polyarteritis Nodosa in a Child: A Case Report
por: Hong, Eun Hye, et al.
Publicado: (2021)

Thyrotoxic periodic paralysis and chorea: two uncommon neuromuscular complications in an adolescent with newly diagnosed Graves disease
por: Nakavachara, Pairunyar, et al.
Publicado: (2013)

Graves’ disease in children less than 8 years of age: review of clinical features and treatment outcome
por: Korula, Sophy, et al.
Publicado: (2015)

Cholestatic liver diseases: An era of emerging therapies
por: Samant, Hrishikesh, et al.
Publicado: (2019)

The Role of Vitamin K in Cholestatic Liver Disease
por: Sultana, Halima, et al.
Publicado: (2021)

Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021)

Guidelines for the Management of Cholestatic Liver Diseases (2021)
por: Lu, Lungen
Publicado: (2022)

Human Hepatocellular response in Cholestatic Liver Diseases
por: Ortiz, Kimberly, et al.
Publicado: (2023)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

Cutaneous polyarteritis nodosa with clinical features of pyoderma gangrenosum
por: Pineider, Juliana, et al.
Publicado: (2020)

Catastrophic Cutaneous Polyarteritis Nodosa Exacerbated by Emotional Stress
por: Bawany, Fatima, et al.
Publicado: (2022)

Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
por: Zeng, Jinhui, et al.
Publicado: (2021)

The Role of Liver Biopsy in Investigation of Cholestatic Liver Disease in Infancy
por: Chaudhry, Zoya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_58s48d3qi25m1e760jmqtuevbs